Zhang Lei portfolio, Q2 2026
HHLR Advisors (Hillhouse) · 13F for the quarter ending Jun 30, 2026
For Q2 2026, HHLR Advisors (Hillhouse) reported $832.1M across 35 US-listed positions, led by LEGN (20.8%), FUTU (19.9%) and AVBP (16.4%). Compared with its filing for Q1 2026, Zhang Lei opened 5 new positions, added to 6, reduced 7 and sold out of 8; 16 positions did not change.
The largest purchase was an addition to VIPS ($44.4M); the largest sale, the sale of the whole position in ONC ($307.2M).
This is the latest filing on file; the main portfolio page shows the same holdings against today's prices.
Key facts
- 13F portfolio value
- $832.1MQ2 2026
- Positions
- 35
- Largest holding
- LEGN 20.8%
- New positions
- 5
- Sold out
- 8
- Filed
- Aug 14, 2026
Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Every tracked investor's Q2 2026 13F.
Bought and sold in Q2 2026
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| Beone Medicines LtdONC | ▼ Sold out | −1.03M | $307.2M | 36.9% |
| PDD Holdings IncPDD | ▼ Reduced 88% | −3.67M | $279.6M | 33.6% |
| Alibaba Group Holding LtdBABA | ▼ Reduced 93% | −2.27M | $217.8M | 26.2% |
| Vipshop Holdings LtdVIPS | ▲ Added more than 10× | +3.35M | $44.4M | 5.33% |
| Futu Holdings LtdFUTU | ▲ Added 25% | +348.8K | $32.7M | 3.93% |
Clearwater Analytics Holdingsno ticker on file | ▼ Sold out | −1.37M | $32.3M | 3.88% |
| KE Holdings IncBEKE | ▼ Reduced 48% | −2.02M | $29.3M | 3.52% |
| Alamar Biosciences IncALMR | ▲ New | +956.46K | $25.9M | 3.11% |
| Odyssey Therapeutics IncODTX | ▲ New | +831.66K | $15.6M | 1.87% |
| Webull CorpBULL | ▼ Reduced 79% | −1.19M | $7.8M | 0.93% |
| NetEase IncNTES | ▲ New | +35K | $4.5M | 0.54% |
| Marvell Technology IncMRVL | ▼ Reduced 4.7% | −8.1K | $2.4M | 0.29% |
| Intel CorpINTC | ▼ Reduced 51% | −14.67K | $2M | 0.25% |
| Lumentum Hldgs IncLITE | ▲ Added 120% | +1.8K | $1.5M | 0.19% |
| NVIDIA CorpNVDA | ▲ Added 113% | +7.44K | $1.5M | 0.18% |
| Texas Instruments IncTXN | ▲ New | +4.8K | $1.4M | 0.17% |
| Barrick Mining CorpB | ▼ Sold out | −25.4K | $1M | 0.12% |
| Dingdong Cayman LtdDDL | ▼ Sold out | −354.5K | $911.1K | 0.11% |
| Coherent CorpCOHR | ▲ Added 50% | +2.14K | $845K | 0.10% |
| Zoom Communications IncZM | ▲ New | +9.01K | $777.7K | 0.09% |
Centrais Elet Bras SAno ticker on file | ▼ Sold out | −63.1K | $711.8K | 0.09% |
| iShares IncEWW | ▼ Sold out | −8.8K | $662K | 0.08% |
| Corning IncGLW | ▲ Added 33% | +2.57K | $655.4K | 0.08% |
| Vnet Group IncVNET | ▼ Sold out | −65.1K | $546.2K | 0.07% |
| Uxin LtdUXIN | ▼ Sold out | −19.16K | $58.8K | 0.01% |
| Taiwan Semiconductor Manufacturing Company LtdTSM | ▼ Reduced 0.06% | −10 | $4.8K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2026 |
|---|---|---|---|---|---|---|---|---|
| 1 | Legend Biotech CorpLEGN · SPONSORED ADS | Health Care | 20.8% | $172.8M | 5.98M | $28.88 | 9+ qtrs | No change |
| 2 | Futu Holdings LtdFUTU · SPON ADS CL A | Financials | 19.9% | $165.8M | 1.77M | $93.74 | 9+ qtrs | ▲ Added 25% |
| 3 | Arrivent Biopharma IncAVBP | — | 16.4% | $136.5M | 3.93M | $34.74 | 9+ qtrs | No change |
| 4 | Marvell Technology IncMRVL | Technology | 5.83% | $48.5M | 162.93K | $297.89 | 2 qtrs | ▼ Reduced 4.7% |
| 5 | Vipshop Holdings LtdVIPS · SPONSORED ADS A | Consumer Discretionary | 5.53% | $46M | 3.47M | $13.26 | 2 qtrs | ▲ Added more than 10× |
| 6 | PDD Holdings IncPDD · SPONSORED ADS | Consumer Discretionary | 4.58% | $38.1M | 500K | $76.28 | 9+ qtrs | ▼ Reduced 88% |
| 7 | KE Holdings IncBEKE · SPONSORED ADS | Real Estate | 3.87% | $32.2M | 2.22M | $14.53 | 9+ qtrs | ▼ Reduced 48% |
| 8 | Cytek Biosciences IncCTKB | — | 3.54% | $29.5M | 6.66M | $4.43 | 9+ qtrs | No change |
| 9 | Alamar Biosciences IncALMR | — | 3.11% | $25.9M | 956.46K | $27.09 | 1 qtr | New |
| 10 | Alibaba Group Holding LtdBABA · SPONSORED ADS | Consumer Discretionary | 2.12% | $17.7M | 183.93K | $95.98 | 9+ qtrs | ▼ Reduced 93% |
| 11 | Odyssey Therapeutics IncODTX | — | 1.87% | $15.6M | 831.66K | $18.71 | 1 qtr | New |
| 12 | Yatsen Holding LtdYSG · SPONSORED ADS | — | 1.86% | $15.5M | 4.89M | $3.17 | 9+ qtrs | No change |
| 13 | Novabridge BiosciencesNBP · SPONSORED ADS | — | 1.40% | $11.7M | 5.98M | $1.95 | 9+ qtrs | No change |
| 14 | Contineum Therapeutics IncCTNM · CL A | — | 1.32% | $11M | 669.34K | $16.39 | 9+ qtrs | No change |
| 15 | Maze Therapeutics IncMAZE | — | 1.31% | $10.9M | 366.03K | $29.84 | 6 qtrs | No change |
| 16 | Agora IncAPI · ADS | — | 1.01% | $8.4M | 2.1M | $3.99 | 7 qtrs | No change |
| 17 | Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADS | Technology | 0.89% | $7.4M | 15.51K | $477.57 | 3 qtrs | ▼ Reduced 0.06% |
| 18 | Sagimet Biosciences IncSGMT | — | 0.67% | $5.6M | 724.8K | $7.73 | 9+ qtrs | No change |
| 19 | NetEase IncNTES · SPONSORED ADS | Technology | 0.54% | $4.5M | 35K | $128.14 | 1 qtr | New |
| 20 | GE AerospaceGE | Industrials | 0.45% | $3.8M | 10.04K | $373.73 | 9+ qtrs | No change |
| 21 | Lumentum Hldgs IncLITE | Technology | 0.34% | $2.8M | 3.3K | $858.06 | 2 qtrs | ▲ Added 120% |
| 22 | NVIDIA CorpNVDA | Technology | 0.34% | $2.8M | 14.05K | $200.09 | 2 qtrs | ▲ Added 113% |
| 23 | Tuya IncTUYA · SPONSERED ADS | — | 0.33% | $2.8M | 1.56M | $1.76 | 9+ qtrs | No change |
| 24 | Corning IncGLW | Technology | 0.32% | $2.6M | 10.27K | $255.43 | 2 qtrs | ▲ Added 33% |
| 25 | Coherent CorpCOHR | Technology | 0.30% | $2.5M | 6.42K | $394.47 | 2 qtrs | ▲ Added 50% |
| 26 | Webull CorpBULL · ORD SHS | — | 0.24% | $2M | 309.86K | $6.52 | 5 qtrs | ▼ Reduced 79% |
| 27 | Intel CorpINTC | Technology | 0.24% | $2M | 14.3K | $139.63 | 2 qtrs | ▼ Reduced 51% |
| 28 | Pacific Biosciences of California IncPACB | — | 0.19% | $1.5M | 918.89K | $1.68 | 9+ qtrs | No change |
| 29 | Texas Instruments IncTXN | Technology | 0.17% | $1.4M | 4.8K | $298.07 | 1 qtr | New |
| 30 | Mogu IncMOGU · SPON ADS | — | 0.17% | $1.4M | 847.51K | $1.67 | 9+ qtrs | No change |
| 31 | Gossamer Bio IncGOSS | — | 0.10% | $818.7K | 4.97M | $0.1646 | 9+ qtrs | No change |
| 32 | Equinox Gold CorpEQX | Materials | 0.09% | $782.5K | 80.5K | $9.72 | 4 qtrs | No change |
| 33 | Zoom Communications IncZM · CL A | Technology | 0.09% | $777.7K | 9.01K | $86.31 | 1 qtr | New |
| 34 | Aligos Therapeutics IncALGS | — | 0.05% | $439.9K | 76.25K | $5.77 | 9+ qtrs | No change |
| 35 | Ridgetech IncRDGT · SHS NEW | — | 0.00% | $204 | 136 | $1.50 | 9+ qtrs | — |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Health Care | 20.8% | $172.8M | 1 |
| Financials | 19.9% | $165.8M | 1 |
| Consumer Discretionary | 12.2% | $101.8M | 3 |
| Technology | 9.07% | $75.4M | 10 |
| Real Estate | 3.87% | $32.2M | 1 |
| Industrials | 0.45% | $3.8M | 1 |
| Materials | 0.09% | $782.5K | 1 |
| No sector on file | 33.6% | $279.5M | 17 |
Questions and answers
What did Zhang Lei own in Q2 2026?
HHLR Advisors (Hillhouse)'s 13F for Q2 2026 lists 35 positions worth $832.1M. The largest: LEGN (20.8%), FUTU (19.9%), AVBP (16.4%), MRVL (5.8%), VIPS (5.5%).
What did Zhang Lei buy in Q2 2026?
The largest purchases, by the shares bought at the quarter-end price the filing implies: VIPS (added, $44.4M), FUTU (added, $32.7M), ALMR (new, $25.9M), ODTX (new, $15.6M), NTES (new, $4.5M), LITE (added, $1.5M).
What did Zhang Lei sell in Q2 2026?
The largest sales: ONC (sold out, $307.2M), PDD (reduced, $279.6M), BABA (reduced, $217.8M), Clearwater Analytics Holdings (sold out, $32.3M), BEKE (reduced, $29.3M), BULL (reduced, $7.8M).
When was this filing made?
HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Zhang Lei portfolio, Q2 2026: HHLR Advisors (Hillhouse) 13F holdings”, data as of 14 August 2026. https://funkfolio.com/gurus/hillhouse/2026-q2
Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Jun 30, 2026.
Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Jun 30, 2026, filed Aug 14, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $832.1M reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 9 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.